• Most Popular
  • Most Shared

Galapagos in osteoporosis deal with Eli Lilly

BRUSSELS
Wed Dec 19, 2007 2:37am EST

Stocks

   

BRUSSELS (Reuters) - Belgian biotechnology company Galapagos (GLPG.BR)(GLPG.AS) said on Wednesday it struck a global collaboration agreement with U.S. pharmaceutical group Eli Lilly (LLY.N) to develop new medicines for treating osteoporosis.

Deals  |  Stocks

Galapagos will provide Lilly access to 12 of its osteoporosis targets, that may play a key role in bone formation, and Galapagos will be responsible for development of drug candidates potentially through to phase IIa clinical Proof of Concept, it said in a statement.

Galapagos specializes in bone and joint diseases such as rheumatoid arthritis and osteoporosis.
Deals
Stocks


More from Reuters

Photo

U.S. official admits security failed in air scare

WASHINGTON (Reuters) - A regional wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane, saying it was to avenge U.S. attacks on the group in Yemen. | Video

» More Top News
Passengers queue to go through security checks at the departure gate at Gatwick Airport, in southern England December 28, 2009. REUTERS/Luke MacGregor

Travel headaches after scare

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

U.S.
A man yells at the site of suicide bomb attack on a procession of Shit'ite Muslims commemorating Ashura in Karachi December 28, 2009. Credit: REUTERS/Athar Hussain

"Worse than an infidel"

Dozens killed as suicide bomber attacks Shi'ite Muslim progression in Pakistan despite thousands of security forces on high alert.   Full Article | Video 

World